Role of VASP Phosphorylation Assay in Monitoring the Antiplatelet Therapy

1. O’Connor S, Montalescot G, Collet JP. The P2Y12 receptor as a target of antithrombotic drugs. Purinergic Signalling 2011; 7: 325-332.10.1007/s11302-011-9241-zSearch in Google Scholar

2. Cattaneo M. , Aspirin and Clopidogrel : Efficacy, Safety, and the Issue of Drug ResistanceArteriosclerosis, Thrombosis, and Vascular Biology. 2004; 24: 1980-1987)10.1161/01.ATV.0000145980.39477.a9Search in Google Scholar

3. Montalescot G, Wiviott SD, Braunwald E, et al for the TRITON-TIMI 38 investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009; 373: 723-73110.1016/S0140-6736(09)60441-4Search in Google Scholar

4. Bonaca MP, Steg PG, Feldman L, Canales JF, Ferguson J, Wallentin L, Califf RM, et al. Antithrombotics in Acute Coronary Syndromes. J Am Coll Cardiol 2009; 54, 11: 969- 984.10.1016/j.jacc.2009.03.08319729112Search in Google Scholar

5. Cattaneo M. Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution? J Thromb Haemost 2012; 10: 327-36.Search in Google Scholar

6. Wang X, Zhang D, Zhuang S, Lai Y. Modifying Clopidogrel Maintenance Doses According to Vasodilator- Stimulated Phosphoprotein Phosphorylation Index Improves Clinical Outcome in PatientsWith Clopidogrel Resistance. Clin Cardiol 2011; 34, 5, 332-338.10.1002/clc.20884665272621538380Search in Google Scholar

7. Wallentin L, et al. P2Y12 inhibitors : differences in properties and mechanisms of action and potential consequences for clinical use. European Heart Journal 2009; 30, 1964-1977.10.1093/eurheartj/ehp29619633016Search in Google Scholar

8. Buonamici P, Marcucci R, Migliorini A, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 2007; 49: 2312-7.10.1016/j.jacc.2007.01.09417572245Search in Google Scholar

9. Gachet C, B.Aleil B, Testing antiplatelet therapy. European Heart Journal Supplements 2008; 10 (Suppl A), A28-A34.10.1093/eurheartj/sum081Search in Google Scholar

10. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005; 3: 85-92.10.1111/j.1538-7836.2004.01063.x15634270Search in Google Scholar

11. STAGO - Biocytex ® (France), Manual for PLT VASP/P2Y12 kit; http://www.american-diagnostica.de/fileadmin/ user_upload/Biocytex/7014-english.pdfSearch in Google Scholar

12. Bonello L, Camoin-Jau L, Armero S, et al. Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis. Am J Cardiol. 2009;103:5-10.10.1016/j.amjcard.2008.08.04819101221Search in Google Scholar